MB MAINLINE BIOSCIENCES
Live / Applied — Statement of use — registration review complete (as of 01 Apr 2026)
What this means for you
Not registered yet, but its 18 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97683356
- Mark type
- Word mark
- Filed
- 18 Nov 2022
- Published for opposition
- 14 Jan 2025
- Attorney of record
- Don D. Cha
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of cancer or tumor; Pharmaceutical preparations for the treatment and prevention of cancer or tumor; Pharmaceutical preparations for the treatment of cancer or tumor; Pharmaceutical preparations for cancer or tumor; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Therapeutic pharmaceutical for the treatment of cancer or tumor
- Class 042 — Scientific and technological services: Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Testing of pharmaceuticals
Owner
- Mainline Biosciences (Shanghai) Co., Ltd., Lingang, Shanghai, CN
- Mainline Biosciences (Shanghai) Co., Ltd., Lingang, Shanghai, CN
Prosecution history
- 01 Apr 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Apr 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Apr 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Oct 2025 — USE AMENDMENT FILED
- 13 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 13 Oct 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 13 Oct 2025 — NOTICE OF REVIVAL - E-MAILED
- 13 Oct 2025 — PETITION TO REVIVE-GRANTED
- 13 Oct 2025 — TEAS PETITION TO REVIVE RECEIVED
- 13 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 13 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 11 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Jan 2025 — PUBLISHED FOR OPPOSITION
- 08 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED